Loading...

Qilian International Holding Group Limited

QLINASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$5.41
$-0.20(-3.57%)

Qilian International Holding Group Limited (QLI) Stock Competitors & Peer Comparison

See (QLI) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
QLI$5.41-3.57%38.7M-4.92-$1.10N/A
ZTS$152.82-0.41%68.1B27.50$5.56+1.26%
TAK$14.66-0.54%46.3B63.70$0.23+4.02%
HLN$9.85+1.03%44.3B23.48$0.42+1.71%
TEVA$16.33-1.51%18.8B-14.22-$1.15N/A
ITCI$131.87+0.00%14B-180.64-$0.73N/A
NBIX$131.64-1.51%13B44.62$2.95N/A
RDY$14.71+0.75%12.2B18.62$0.79+0.65%
CTLT$63.48+0.00%11.5B-27.84-$2.28N/A
VTRS$9.35-0.21%11B-2.94-$3.18+5.15%
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

QLI vs ZTS Comparison July 2025

QLI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, QLI stands at 38.7M. In comparison, ZTS has a market cap of 68.1B. Regarding current trading prices, QLI is priced at $5.41, while ZTS trades at $152.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

QLI currently has a P/E ratio of -4.92, whereas ZTS's P/E ratio is 27.50. In terms of profitability, QLI's ROE is -0.16%, compared to ZTS's ROE of +0.51%. Regarding short-term risk, QLI is less volatile compared to ZTS. This indicates potentially lower risk in terms of short-term price fluctuations for QLI.Check ZTS's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions

;